Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Cohbar Inc (CWBR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 332,068
  • Shares Outstanding, K 39,960
  • Annual Sales, $ 0 K
  • Annual Income, $ -9,830 K
  • 36-Month Beta 4.04
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 62.51

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.51 +50.82%
on 05/25/18
10.79 -22.98%
on 06/13/18
+2.25 (+37.13%)
since 05/22/18
3-Month
4.44 +87.16%
on 04/20/18
10.79 -22.98%
on 06/13/18
+3.19 (+62.30%)
since 03/22/18
52-Week
1.61 +416.15%
on 07/10/17
10.79 -22.98%
on 06/13/18
+6.66 (+403.64%)
since 06/20/17

Most Recent Stories

More News
CohBar Announces the Appointment of Dr. Philippe Calais to its Board

CohBar, Inc. (NASDAQ:CWBR) ("CohBar" or the "Company"), an innovative biotechnology company developing mitochondria based therapeutics (MBTs) to treat age-related diseases, today announced the appointment...

CWBR : 8.31 (-11.12%)
MRNA : 0.9100 (unch)
CohBar to Hold 2018 Annual Shareholder Meeting and Investor Update, June 19, 2018

CohBar, Inc. (NASDAQ:CWBR) ("CohBar" or the "Company"), an innovative biotechnology company developing mitochondria based therapeutics (MBTs) to treat age-related diseases, is hosting its Annual Shareholder...

CWBR : 8.31 (-11.12%)
CohBar, Inc. Announces First Quarter 2018 Financial Results

CohBar, Inc. (NASDAQ:CWBR) ("CohBar" or the "Company"), an innovative biotechnology company developing mitochondria based therapeutics (MBTs) to treat age-related diseases, today reported its financial...

CWBR : 8.31 (-11.12%)
CohBar, Inc. Announces Voluntary Delisting from the TSX Venture Exchange

CohBar, Inc. (NASDAQ:CWBR) and (TSXV:COB.U) ("CohBar" or the "Company") today announced that it has applied to voluntarily delist its common shares from the TSX Venture Exchange ("TSXV").

COB-U.VN : 5.000 (+4.17%)
CWBR : 8.31 (-11.12%)
CohBar, Inc. Announces Fourth Quarter 2017 Financial Results

CohBar, Inc. (NASDAQ:CWBR) (TSXV:COB.U) ("CohBar" or the "Company"), an innovative biotechnology company developing mitochondria based therapeutics (MBTs) to treat age-related diseases, today reported...

COB-U.VN : 5.000 (+4.17%)
CWBR : 8.31 (-11.12%)
CohBar, Inc. Announces Closing of First Tranche of Private Placement

CohBar, Inc. (NASDAQ:CWBR) (TSXV:COB.U) ("CohBar" or the "Company") is pleased to announce the closing of its first tranche of its previously announced private placement (the "Private Placement") offering...

COB-U.VN : 5.000 (+4.17%)
CWBR : 8.31 (-11.12%)
CohBar, Inc. Announces Financing of up to US$5,000,000 in Unsecured Promissory Notes

CohBar, Inc. (NASDAQ:CWBR) and (TSXV:COB.U) ("CohBar" or the "Company"), a preclinical stage biotechnology company developing mitochondria based therapeutics to treat age-related diseases, announced today...

COB-U.VN : 5.000 (+4.17%)
CWBR : 8.31 (-11.12%)
CohBar, Inc. to Announce 2017 Fourth Quarter Financial Results and Host Conference Call for Shareholders on April 2, 2018

CohBar, Inc. (NASDAQ:CWBR) (TSXV:COB.U), an innovative biotechnology company developing mitochondria based therapeutics (MBTs) to treat age-related diseases, announced today that the Company will release...

COB-U.VN : 5.000 (+4.17%)
CWBR : 8.31 (-11.12%)
OTC Markets Group Announces Quarterly Index Performance and Rebalancing

OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the fourth quarter 2017 performance and quarterly rebalancing of the OTCQX® and...

TYCB : 37.0500 (unch)
FFMR : 43.1100 (-2.00%)
LOOP : 10.49 (-0.38%)
CFNB : 15.8000 (-0.32%)
WBBW : 22.3300 (+0.59%)
FTNWD : 7.5000 (+6.84%)
BONT : 0.0910 (-39.25%)
NVMM : 1.62 (-2.99%)
AYTUD : 4.1000 (+3.80%)
CWBR : 8.31 (-11.12%)
ALBY : 2.5500 (unch)
LLPP : 13.8500 (-1.07%)
LHSIF : 0.7800 (+15.95%)
HEOFF : 0.9007 (-2.43%)
PFBX : 13.8500 (-1.07%)
VLLX : 33.5000 (+4.69%)
OTCM : 27.8100 (-3.34%)
FCBP : 29.01 (+1.19%)
NGLOY : 11.4600 (+3.52%)
IBTN : 17.7700 (+0.11%)
SCQBD : 0.7420 (+1.08%)
FTNW : 20.61 (+1.78%)
WAYN : 19.0000 (-0.26%)
OSTK : 33.45 (-7.47%)
OSTBP : 32.0000 (-7.25%)
CohBar, Inc. to Announce Third Quarter 2017 Financial Results and Host Conference Call for Shareholders on November 13, 2017

CohBar, Inc. (OTCQX:CWBR) (TSXV:COB.U), an innovative biotechnology company focused on developing mitochondria based therapeutics (MBTs) to treat age-related diseases, announced today that the Company...

COB-U.VN : 5.000 (+4.17%)
CWBR : 8.31 (-11.12%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade CWBR with:

Business Summary

Cohbar, Inc. operates is a biotechnology company. It engaged in the research and development of mitochondria-based therapeutics for the treatment of diseases associated with aging. Cohbar, Inc. is based in Menlo Park, California.

See More

Key Turning Points

2nd Resistance Point 9.52
1st Resistance Point 8.92
Last Price 8.31
1st Support Level 7.91
2nd Support Level 7.50

See More

52-Week High 10.79
Last Price 8.31
Fibonacci 61.8% 7.28
Fibonacci 50% 6.20
Fibonacci 38.2% 5.12
52-Week Low 1.61

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar